{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:17:30Z","timestamp":1791317850795,"version":"4.3.1"},"reference-count":68,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[1998,7,1]],"date-time":"1998-07-01T00:00:00Z","timestamp":899251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[1998,7]]},"abstract":"<jats:sec><jats:title>SUMMARY<\/jats:title><jats:p>Although not life-threatening, onychomycosis (a fungal infection of the nail, usually caused by a dermatophyte) constitutes an important public health problem because of its high prevalence (about 10% of the U.S. population) and associated morbidity. The disease can have certain negative consequences for patients, such as pain, and can potentially undermine work and social lives. This review discusses the etiology, classification, diagnosis, and treatment of onychomycosis. Four types of onychomycosis are recognized based on the site and pattern of fungal invasion. Dermatophyte fungi are the predominant pathogens, but yeasts (especially Candida albicans) and nondermatophyte molds may also be implicated. Accurate diagnosis requires direct microscopy and fungal culture. The differential diagnosis includes psoriasis, lichen planus, onychogryphosis, and nail trauma. Onychomycosis is more difficult to treat than most dermatophytoses because of the inherent slow growth of the nail. Older antifungal agents (ketoconazole and griseofulvin) are unsuitable for onychomycosis because of their relatively poor efficacy and potential adverse effects. Three recently developed antimycotic agents (fluconazole, itraconazole, and terbinafine) offer high cure rates and good safety profiles. In addition, the short treatment times (&lt;3 months) and intermittent dosing schedules are likely to enhance compliance and reduce the costs of therapy.<\/jats:p><\/jats:sec>","DOI":"10.1128\/cmr.11.3.415","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T16:31:07Z","timestamp":1539966667000},"page":"415-429","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":427,"title":["Onychomycosis: Pathogenesis, Diagnosis, and Management"],"prefix":"10.1128","volume":"11","author":[{"given":"Boni E.","family":"Elewski","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Dermatology, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0190-9622(08)81262-5","article-title":"Ecology and epidemiology of dermatophyte infections.","volume":"31","author":"Aly R.","year":"1994","unstructured":"Aly R. Ecology and epidemiology of dermatophyte infections. J. Am. Acad. Dermatol. 31 1994 S21 S25","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","unstructured":"Aly R. and T. Berger. 1996. Common superficial fungal infections in patients with AIDS. Clin. Infect. Dis. 22 (Suppl. 2) : S128\u2013S132.","DOI":"10.1093\/clinids\/22.Supplement_2.S128"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-4362.1987.tb02287.x","article-title":"Onychomycosis.","volume":"26","author":"Andr\u00e9 J.","year":"1987","unstructured":"Andr\u00e9 J. Achten G. Onychomycosis. Int. J. Dermatol. 26 1987 481 490","journal-title":"Int. J. Dermatol."},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-4362.1995.tb03600.x","article-title":"Open randomized comparison of itraconazole versus terbinafine in onychomycosis.","volume":"34","author":"Arenas R","year":"1995","unstructured":"Arenas R Dominguez-Cherit J. Fernandez L. M. Open randomized comparison of itraconazole versus terbinafine in onychomycosis. Int. J. Dermatol. 34 1995 138 143","journal-title":"Int. J. Dermatol."},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/bmj.311.7010.919","article-title":"Randomized double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection.","volume":"311","author":"Brautigam M.","year":"1995","unstructured":"Brautigam M. Nolting S. Schoff R. E. Weidinger G. for the Seventh Lamisil German Onychomycosis Study Group Randomized double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Br. Med. J. 311 1995 919 922","journal-title":"Br. Med. J."},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3810\/pgm.1997.04.209","article-title":"Superficial fungal infections: errors to avoid in diagnosis and treatment.","volume":"101","author":"Brodell R. T.","year":"1997","unstructured":"Brodell R. T. Elewski B. E. Superficial fungal infections: errors to avoid in diagnosis and treatment. Postgrad. Med. 101 1997 279 287","journal-title":"Postgrad. Med."},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-4362.1995.tb01599.x","article-title":"Cutaneous fungal infections: innovative treatment schedules with systemic agents.","volume":"34","author":"Brody N.","year":"1995","unstructured":"Brody N. Cutaneous fungal infections: innovative treatment schedules with systemic agents. Int. J. Dermatol. 34 1995 284 289","journal-title":"Int. J. Dermatol."},{"key":"e_1_3_1_9_2","first-page":"43","article-title":"A historical perspective on onychomycosis.","volume":"3","author":"Charif M. A.","year":"1997","unstructured":"Charif M. A. Elewski B. E. A historical perspective on onychomycosis. Dermatol. Ther. 3 1997 43 45","journal-title":"Dermatol. Ther."},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","unstructured":"Clayton Y. M. and R. J. Hay. 1993. Epidemiology of fungal skin and nail disease: roundtable discussion held at Dermatology 2000 Vienna 17 May 1993. Br. J. Dermatol. 130 (Suppl. 4) : 9\u201311.","DOI":"10.1111\/j.1365-2133.1994.tb06085.x"},{"key":"e_1_3_1_11_2","first-page":"2","article-title":"New strategies for the effective management of superficial fungal infections.","volume":"16","author":"Clinical Courier","year":"1997","unstructured":"Clinical Courier New strategies for the effective management of superficial fungal infections. Clin. Courier 16 1997 2 3","journal-title":"Clin. Courier"},{"key":"e_1_3_1_12_2","first-page":"2","article-title":"Superficial fungal infections: diagnosis and management of onychomycosis.","volume":"12","author":"Clinical Courier","year":"1994","unstructured":"Clinical Courier Superficial fungal infections: diagnosis and management of onychomycosis. Clin. Courier 12 1994 2","journal-title":"Clin. Courier"},{"key":"e_1_3_1_13_2","unstructured":"Cohen J. L. Scher R. K. Pappert A. S. The nail and fungus infections Cutaneous fungal infections. Elewski B. 1992 106 122 Igaku-Shoin Inc. New York N.Y"},{"key":"e_1_3_1_14_2","unstructured":"Davies R. R. Griseofulvin Antifungal chemotherapy. Speller D. C. E. 1980 149 182 John Wiley & Sons Ltd. Chichester England"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","unstructured":"De Backer P. P. De Keyser C. De Vroey and E. Lesaffre. 1996. A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg\/day vs. itraconazole 200 mg\/day\u2014a double-blind comparative trial. Br. J. Dermatol. 134 (Suppl. 46) : 16\u201317.","DOI":"10.1111\/j.1365-2133.1996.tb15653.x"},{"key":"e_1_3_1_16_2","first-page":"353","article-title":"Short-term itraconazole versus terbinafine in the treatment of superficial dermatomycosis of the glabrous skin (tinea corporis or cruris).","volume":"7","author":"Decroix J.","year":"1997","unstructured":"Decroix J. Fritsch P. Picoto A. Thr\u00fclimann W. Degreef H. Short-term itraconazole versus terbinafine in the treatment of superficial dermatomycosis of the glabrous skin (tinea corporis or cruris). Eur. J. Dermatol. 7 1997 353 357","journal-title":"Eur. J. Dermatol."},{"key":"e_1_3_1_17_2","first-page":"46","article-title":"Pharmacokinetics of oral antifungal agents.","volume":"3","author":"De Doncker P.","year":"1997","unstructured":"De Doncker P. Pharmacokinetics of oral antifungal agents. Dermatol. Ther. 3 1997 46 57","journal-title":"Dermatol. Ther."},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archderm.132.1.34","article-title":"Antifungal pulse therapy for onychomycosis: a pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole.","volume":"132","author":"De Doncker P.","year":"1996","unstructured":"De Doncker P. Decroix J. Pierard G. E. Roelant D. Woesternborghs R. Jacqmin P. Odds F. Heremans A. Dockx P. Roseeuw D. Antifungal pulse therapy for onychomycosis: a pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole. Arch. Dermatol. 132 1996 34 41","journal-title":"Arch. Dermatol."},{"key":"e_1_3_1_19_2","first-page":"339","article-title":"Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis.","volume":"97","author":"Del Rosso J. Q.","year":"1997","unstructured":"Del Rosso J. Q. Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis. J. Am. Osteopath. Assoc. 97 1997 339 345","journal-title":"J. Am. Osteopath. Assoc."},{"key":"e_1_3_1_20_2","first-page":"75","article-title":"Oral antifungal agents: recognition and management of adverse reactions.","volume":"15","author":"Del Rosso J. Q.","year":"1997","unstructured":"Del Rosso J. Q. Gupta A. K. Oral antifungal agents: recognition and management of adverse reactions. Today\u2019s Ther. Trends 15 1997 75 84","journal-title":"Today\u2019s Ther. Trends"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-4362.1990.tb04755.x","article-title":"Onychomycosis and AIDS: clinical and laboratory findings in 62 patients.","volume":"29","author":"Dompmartin D.","year":"1990","unstructured":"Dompmartin D. Dompmartin A. Deluol A. M. Grosshans E. Coulaud J. P. Onychomycosis and AIDS: clinical and laboratory findings in 62 patients. Int. J. Dermatol. 29 1990 337 339","journal-title":"Int. J. Dermatol."},{"key":"e_1_3_1_22_2","unstructured":"Drake L. D. Babel D. M. Stewart P. Rich M. R. Ling D. Breneman R. K. Sher A. G. Martin D. M. Pariser R. J. Pariser C. N. Ellis D. Friedman H. I. Katz C. J. McDonald J. Muglia R. C. Savin G. Webster B. E. Elewski J. J. Leyden A. D. Monroe E. H. Tschen J. M. Hanifin M. R. Morman J. L. Shupack N. Levine N. J. Lowe W. F. Bergfeld C. Camisa D. S. Feingold N. Konnikov R. B. Odom R. Aly and D. L. Greer. A placebo-controlled randomized double-blind trial of once-weekly fluconazole (150 300 or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail. J. Am. Acad. Dermatol. in press."},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90843-9"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1365-2133.1997.tb03954.x","article-title":"Cholestatic jaundice due to terbinafine.","volume":"136","author":"Dwyer C. M.","year":"1997","unstructured":"Dwyer C. M. White M. I. Sinclair T. S. Cholestatic jaundice due to terbinafine. Br. J. Dermatol. 136 1997 968 981","journal-title":"Br. J. Dermatol."},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(09)80305-8"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0190-9622(95)90075-6","article-title":"Clinical pearl: diagnosis of onychomycosis.","volume":"32","author":"Elewski B. E.","year":"1995","unstructured":"Elewski B. E. Clinical pearl: diagnosis of onychomycosis. J. Am. Acad. Dermatol. 32 1995 500 501","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/archderm.1997.03890460143029","article-title":"Large scale epidemiological study of the causal agents of onychomycosis: mycological findings from the multicenter onychomycosis study of terbinafine.","volume":"133","author":"Elewski B. E.","year":"1997","unstructured":"Elewski B. E. Large scale epidemiological study of the causal agents of onychomycosis: mycological findings from the multicenter onychomycosis study of terbinafine. Arch. Dermatol. 133 1997 1317 1318","journal-title":"Arch. Dermatol."},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/archderm.1997.03890450124022","article-title":"Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions.","volume":"133","author":"Elewski B. E.","year":"1997","unstructured":"Elewski B. E. Charif M. A. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch. Dermatol. 133 1997 1172 1173 (Letter.)","journal-title":"Arch. Dermatol."},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/clinids\/23.2.305","article-title":"Update on the management of onychomycosis: highlights of the third annual international summit on cutaneous antifungal therapy.","volume":"23","author":"Elewski B. E.","year":"1996","unstructured":"Elewski B. E. Hay R. J. Update on the management of onychomycosis: highlights of the third annual international summit on cutaneous antifungal therapy. Clin. Infect. Dis. 23 1996 305 313","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_30_2","first-page":"217","article-title":"Double-blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis.","volume":"59","author":"Elewski B. E.","year":"1997","unstructured":"Elewski B. E. Scher R. K. Aly R. Daniel R. III Jones H. E Odom R. B. Zaias N. Jacko M. L. Double-blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis. Cutis 59 1997 217 220","journal-title":"Cutis"},{"key":"e_1_3_1_31_2","unstructured":"Elewski B. E. Rinaldi M. G. Weitzman I. Diagnosis and treatment of onychomycosis. a clinician\u2019s handbook. 1995 Gardiner-Caldwell SynerMed Califon N.J"},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2133.1997.tb02128.x","article-title":"Non-dermatophytes in onychomycosis of the toenails.","volume":"136","author":"Ellis D. H.","year":"1997","unstructured":"Ellis D. H. Watson A. B. Marley J. E. Williams T. G. Non-dermatophytes in onychomycosis of the toenails. Br. J. Dermatol. 136 1997 490 493","journal-title":"Br. J. Dermatol."},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","unstructured":"Ellis D. H. J. E. Marley A. B. Watson and T. G. Williams. 1997. Significance of non-dermatophyte molds and yeasts in onychomycosis. Dermatology 194 (Suppl. 1) : 40\u201342.","DOI":"10.1159\/000246184"},{"key":"e_1_3_1_34_2","unstructured":"Fraki J. Heikkil\u00e4 H. T. Kero M. O. Kuokkanen K. E. Oksman R. O. Rantanen T. T. Saari S. S. Sten M. L. Stubb S. H. A. Uggeldahl P. E. Fluconazole in the treatment of onychomycosis: an open non-comparative study with oral 150 mg fluconazole once weekly abstr. 14. Dermatology 2000 (symposium) 1991"},{"key":"e_1_3_1_35_2","doi-asserted-by":"crossref","unstructured":"Goodfield M. J. D. 1992. Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial. Br. J. Dermatol. 126 (Suppl. 39) : 33\u201335.","DOI":"10.1111\/j.1365-2133.1992.tb00007.x"},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archderm.132.7.845","article-title":"The development of green vision in association with terbinafine therapy.","volume":"132","author":"Gupta A. K.","year":"1996","unstructured":"Gupta A. K. The development of green vision in association with terbinafine therapy. Arch Dermatol. 132 1996 845 846","journal-title":"Arch Dermatol."},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0190-9622(97)80293-9","article-title":"Hypersensitivity reaction to terbinafine.","volume":"36","author":"Gupta A. K.","year":"1997","unstructured":"Gupta A. K. Kopstein J. B. Shear N. H. Hypersensitivity reaction to terbinafine. J. Am. Acad. Dermatol. 36 1997 1018 1019","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_1_38_2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(97)80215-0","article-title":"Onychomycosis in children: prevalence and treatment strategies.","volume":"36","author":"Gupta A. K.","year":"1997","unstructured":"Gupta A. K. Sibbald R. G. Lynde C. W. Hull P. R. Prussick R. Shear N. H. De Doncker P. Daniell C. R. III Elewski B. E. Onychomycosis in children: prevalence and treatment strategies. J. Am. Acad. Dermatol. 36 1997 395 402","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_1_39_2","first-page":"230","article-title":"A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis.","volume":"136","author":"Havu V.","year":"1997","unstructured":"Havu V. Brandt H. Heikkil\u00e4 H. Hollne A. Oksman R. Rantanen T. Saari S. Stubb S. Turjanmaa K. Piepponen T. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis. Br. J. Dermatol. 136 1997 230 234","journal-title":"Br. J. Dermatol."},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/adc.67.9.1065","article-title":"Fungal skin infections.","volume":"67","author":"Hay R. J.","year":"1992","unstructured":"Hay R. J. Fungal skin infections. Arch. Dis. Child. 67 1992 1065 1067","journal-title":"Arch. Dis. Child."},{"key":"e_1_3_1_41_2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2133.1995.tb02741.x","article-title":"The prevalence of onychomycosis in Finland.","volume":"133","author":"Heikkal\u00e4 H.","year":"1995","unstructured":"Heikkal\u00e4 H. Stubbs S. The prevalence of onychomycosis in Finland. Br. J. Dermatol. 133 1995 699 701","journal-title":"Br. J. Dermatol."},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1468-3083.1997.tb00505.x","article-title":"Itraconazole versus terbinafine (LAMISIL\u00ae): which is better for the treatment of onychomycosis?","volume":"9","author":"Honeyman J. F.","year":"1997","unstructured":"Honeyman J. F. Talarico F. S. Arruda L. H. F. Pereira A. C. Jr. Santamaria J. R. Souza E. M. Woscoff A. Amorim F. R. de la Parra C. R. Enokihara M. Y. Gavazoni M. F. Gubelin H. W. Rosa S. P. Turini M. A. G. Vitale M. A. Itraconazole versus terbinafine (LAMISIL\u00ae): which is better for the treatment of onychomycosis? J. Eur. Acad. Dermatol. Venereol. 9 1997 215 221","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"e_1_3_1_43_2","unstructured":"Janssen Pharmaceutica Itraconazole package insert. 1997 Janssen Pharmaceutica Titusville N.J"},{"key":"e_1_3_1_44_2","unstructured":"Janssen Pharmaceutica Ketoconazole package insert. 1997 Janssen Pharmaceutica Titusville N.J"},{"key":"e_1_3_1_45_2","unstructured":"Junquiera L. C. Carneiro J. Kelley R. O. Basic histology 8th ed. 1995 353 355 Appleton & Lange Stamford Conn"},{"key":"e_1_3_1_46_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/09546639209088703","article-title":"Fluconazole in the treatment of onychomycosis caused by dermatophytes.","volume":"3","author":"Kuokkanen K.","year":"1993","unstructured":"Kuokkanen K. Alava S. Fluconazole in the treatment of onychomycosis caused by dermatophytes. J. Dermatol. Treat. 3 1993 115 117","journal-title":"J. Dermatol. Treat."},{"key":"e_1_3_1_47_2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2230.1991.tb00405.x","article-title":"Itraconazole penetrates the nail via the nail matrix and the nail bed: an investigation in onychomycosis.","volume":"16","author":"Matthieu L.","year":"1991","unstructured":"Matthieu L. De Doncker P. Cauwenbergh G. Woestenborghs R. van de Velde V. Janssen P. A. Dockx P. Itraconazole penetrates the nail via the nail matrix and the nail bed: an investigation in onychomycosis. Clin. Exp. Dermatol. 16 1991 374 376","journal-title":"Clin. Exp. Dermatol."},{"key":"e_1_3_1_48_2","doi-asserted-by":"crossref","unstructured":"Nolting S. M. Brautigam and G. Weidinger. 1994. Terbinafine in onychomycosis with involvement by non-dermatophytic fungi. Br. J. Dermatol. 130 (Suppl. 43) : 16\u201321.","DOI":"10.1111\/j.1365-2133.1994.tb06088.x"},{"key":"e_1_3_1_49_2","unstructured":"Novartis Pharmaceuticals Corporation Terbinafine package insert. 1997 Novartis Pharmaceuticals Corp. E. Hanover N.J"},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0190-9622(96)90519-8","article-title":"A double-blind, randomized comparison of itraconazole capsules and placebo in the treatment of onychomycosis of the toenail.","volume":"35","author":"Odom R.","year":"1996","unstructured":"Odom R. Daniel C. R. III Aly R. A double-blind, randomized comparison of itraconazole capsules and placebo in the treatment of onychomycosis of the toenail. J. Am. Acad. Dermatol. 35 1996 110 111","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0190-9622(97)70286-X","article-title":"A multicenter-placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail.","volume":"36","author":"Odom R. B.","year":"1997","unstructured":"Odom R. B. Aly R. Scher R. K. Daniel C. R. III Elewski B. E. Zaias N. DeVillez R. Jacko M. Oleka N. Moskovitz B. L. A multicenter-placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail. J. Am. Acad. Dermatol. 36 1997 231 235","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_1_52_2","unstructured":"Ortho Diagnostics Griseofulvin package insert. 1997 Ortho Dermatologic Division Raritan N.J"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.2.235"},{"key":"e_1_3_1_54_2","unstructured":"Rippon J. W. Medical mycology: the pathogenic fungi and the pathogenic actinomycetes 3rd ed. 1988 169 275 The W. B. Saunders Co. Philadelphia Pa"},{"key":"e_1_3_1_55_2","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0190-9622(08)81837-3","article-title":"New approaches to the treatment of onychomycosis.","volume":"29","author":"Roseeuw D.","year":"1993","unstructured":"Roseeuw D. De Doncker P. New approaches to the treatment of onychomycosis. J. Am. Acad. Dermatol. 29 1993 S45 S50","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_1_56_2","unstructured":"Scher R. K. Diseases of the nails Current therapy. Conn H. 1990 736 742 The W. B. Saunders Co. Philadelphia Pa"},{"issue":"2","key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0190-9622(96)90061-4","article-title":"Onychomycosis: a significant medical disorder.","volume":"35","author":"Scher R. K.","year":"1996","unstructured":"Scher R. K. Onychomycosis: a significant medical disorder. J. Am. Acad. Dermatol. 35 Part 2 1996 S2 S5","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_1_58_2","unstructured":"Scher R. K. D. Breneman P. Rich R. C. Savin D. S. Feingold N. Konnikov J. L. Shupack S. Pinnell N Levine N. J. Lowe R. Aly R. B. Odom D. L. Greer M. R. Morman A. D. Monroe E. H. Tschen B. E. Elewski and E. B. Smith. A placebo-controlled randomized double-blind trial of once-weekly fluconazole (150 mg 300 mg or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. J. Am. Acad. Dermatol. in press."},{"key":"e_1_3_1_59_2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/02681219080000511","article-title":"Toenail infection caused by Onychocola canadensis gen. et sp. nov.","volume":"28","author":"Sigler L.","year":"1990","unstructured":"Sigler L. Congly H. Toenail infection caused by Onychocola canadensis gen. et sp. nov. J. Med Vet. Mycol. 28 1990 405 17","journal-title":"J. Med Vet. Mycol."},{"key":"e_1_3_1_60_2","doi-asserted-by":"crossref","unstructured":"Summerbell R. C. 1997. Epidemiology and ecology of onychomycosis. Dermatology 194 (Suppl. 1) : 32\u201336.","DOI":"10.1159\/000246182"},{"key":"e_1_3_1_61_2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1439-0507.1989.tb02192.x","article-title":"Onychomycosis, tinea pedis, and tinea manuum caused by non-dermatophytic filamentous fungi.","volume":"32","author":"Summerbell R. C.","year":"1989","unstructured":"Summerbell R. C. Kane J. Krajden S. Onychomycosis, tinea pedis, and tinea manuum caused by non-dermatophytic filamentous fungi. Mycoses 32 1989 609 619","journal-title":"Mycoses"},{"key":"e_1_3_1_62_2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1365-2133.1997.tb03662.x","article-title":"Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy.","volume":"136","author":"Tausch I.","year":"1997","unstructured":"Tausch I. Brautigam M. Weidinger G. Jones T. C. the Lagos V Study Group Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. Br. J. Dermatol. 136 1997 737 742","journal-title":"Br. J. Dermatol."},{"key":"e_1_3_1_63_2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0190-9622(96)80057-0","article-title":"Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy.","volume":"34","author":"Tosti A.","year":"1996","unstructured":"Tosti A. Piraccini B. M. Stinchi C. Venturo N. Bardazzi F. Colombo M. D. Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. J. Am. Acad. Dermatol. 34 1996 595 600","journal-title":"J. Am. Acad. Dermatol."},{"key":"e_1_3_1_64_2","doi-asserted-by":"crossref","unstructured":"Van der Schroeff J. G. P. K. S. Cirkel M. B. Crijns T. J. A. Van Kijk F. J. Govaert D. A. Groeneweg D. J. Tazelaar R. F. E. DeWitt and J. Wuite. 1992. A randomized treatment duration-finding study of terbinafine in onychomycosis. Br. J. Dermatol. 126 (Suppl. 39) : 36\u201339.","DOI":"10.1111\/j.1365-2133.1992.tb00008.x"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.8.2.240"},{"key":"e_1_3_1_66_2","unstructured":"Winn W. C. Jr. Mycotic diseases Clinical diagnosis and management. Henry J. B. 1996 1210 1251 The W. B. Saunders Co. Philadelphia Pa"},{"key":"e_1_3_1_67_2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/archderm.1972.01620050069017","article-title":"Onychomycosis.","volume":"105","author":"Zaias N.","year":"1972","unstructured":"Zaias N. Onychomycosis. Arch. Dermatol. 105 1972 263 274","journal-title":"Arch. Dermatol."},{"key":"e_1_3_1_68_2","first-page":"513","article-title":"Diagnosing and treating onychomycosis.","volume":"42","author":"Zaias N.","year":"1996","unstructured":"Zaias N. Glick B. Rebell G. Diagnosing and treating onychomycosis. J. Fam. Pract. 42 1996 513 518","journal-title":"J. Fam. Pract."},{"issue":"2","key":"e_1_3_1_69_2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0190-9622(96)80142-3","article-title":"Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum.","volume":"34","author":"Zaias N.","year":"1996","unstructured":"Zaias N. Tosti A. Rebell G. Morelli R. Bardazzi F. Bieley H. Zaiac N. Glick B. Paley B. Allevato M. Baran R. Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J. Am. Acad. Dermatol. 34 2 Pt 1 1996 302 304","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.11.3.415","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.11.3.415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T15:34:26Z","timestamp":1720712066000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CMR.11.3.415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,7]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,7]]}},"alternative-id":["10.1128\/CMR.11.3.415"],"URL":"https:\/\/doi.org\/10.1128\/cmr.11.3.415","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,7]]},"assertion":[{"value":"1998-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}